Foghorn Therapeutics Names Jeff Sacher Interim CFO
Foghorn Therapeutics Inc. has appointed Jeff Sacher as interim CFO and Treasurer, effective immediately, while searching for a permanent CFO. Sacher brings experience from biotechnology and investment banking. This announcement was made via EDGAR by Foghorn Therapeutics.
Foghorn Therapeutics Inc. has appointed Jeff Sacher as Treasurer and interim Chief Financial Officer, effective immediately. Sacher, a veteran of the biotechnology and investment banking industries, will serve in the interim role while the company continues its search for a permanent CFO. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Foghorn Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-055215), on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
